Published in IUCrJ · View the paper (DOI)
A new study reveals that serum albumin binds with dexamethasone, a corticosteroid used to treat severe COVID-19, but low albumin levels or diabetes can interfere with this binding, reducing the drug's effectiveness. The researchers suggest doctors may need to adjust dosing for certain patient groups.
Coverage from 2 institutions